Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Titel:
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Auteur:
Rothenberg, Marc E Dellon, Evan S Collins, Margaret H Hirano, Ikuo Chehade, Mirna Bredenoord, Albert J Lucendo, Alfredo J Spergel, Jonathan M Sun, Xian Hamilton, Jennifer D Mortensen, Eric Laws, Elizabeth Maloney, Jennifer Mannent, Leda P McCann, Eilish Liu, Xia Glotfelty, Lila Shabbir, Arsalan